Stockscreener 앱 받기
7.17
0.00%
0.00
시간 외 거래:
7.17
전일 마감가:
$7.17
열려 있는:
$7.21
하루 거래량:
252.19K
Relative Volume:
0.77
시가총액:
$452.95M
수익:
$198.53M
순이익/손실:
$-63.68M
주가수익비율:
-7.0143
EPS:
-1.0222
순현금흐름:
$-41.50M
1주 성능:
-2.32%
1개월 성능:
+28.26%
6개월 성능:
-21.47%
1년 성능:
+31.56%
1일 변동 폭
$7.01
$7.31
1주일 범위
$6.96
$7.47
52주 변동 폭
$4.54
$10.79
트리스 메디컬 컨셉트 Stock (TMCI) Company Profile
명칭
Treace Medical Concepts Inc
전화
(904) 373-5940
주소
100 PALMETTO PARK PLACE, PONTE VEDRA
TMCI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
7.17 | 452.95M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
132.94 | 231.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.22 | 158.98B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
392.31 | 150.76B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.90 | 119.10B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.94 | 47.53B | 5.69B | 1.41B | 577.90M | 6.95 |
트리스 메디컬 컨셉트 Stock (TMCI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-04 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-12-31 | 개시 | Lake Street | Buy |
| 2024-12-17 | 재개 | JP Morgan | Neutral |
| 2024-05-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-08 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-05-08 | 다운그레이드 | Truist | Buy → Hold |
| 2023-09-29 | 개시 | UBS | Buy |
| 2023-05-01 | 개시 | Truist | Buy |
| 2023-04-11 | 개시 | Stephens | Equal-Weight |
| 2022-05-12 | 개시 | BTIG Research | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | 개시 | JP Morgan | Overweight |
| 2021-05-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-05-18 | 개시 | SVB Leerink | Outperform |
| 2021-05-18 | 개시 | Stifel | Buy |
모두보기
트리스 메디컬 컨셉트 주식(TMCI)의 최신 뉴스
Measuring Treace Medical Concepts Inc.’s beta against major indicesBond Market & Safe Entry Point Alerts - Newser
Using Python tools to backtest Treace Medical Concepts Inc. strategiesJuly 2025 Outlook & Comprehensive Market Scan Reports - Newser
PDT Partners LLC Has $709,000 Holdings in Treace Medical Concepts, Inc. $TMCI - MarketBeat
Live market analysis of Treace Medical Concepts Inc.Gold Moves & Fast Exit and Entry Strategy Plans - Newser
What high frequency data says about Treace Medical Concepts Inc.2025 Technical Overview & Stock Timing and Entry Methods - Newser
Can Treace Medical Concepts Inc. be recession proofDay Trade & Risk Controlled Stock Pick Alerts - خودرو بانک
Sentiment analysis tools applied to Treace Medical Concepts Inc.2025 Biggest Moves & Free High Accuracy Swing Entry Alerts - Newser
Driehaus Capital Management LLC Takes Position in Treace Medical Concepts, Inc. $TMCI - MarketBeat
Is Treace Medical Concepts Inc. a defensive stockMarket Risk Report & Growth Oriented Trade Recommendations - خودرو بانک
How to build a custom watchlist for Treace Medical Concepts Inc.Quarterly Portfolio Review & Daily Profit Focused Screening - Newser
Understanding Treace Medical Concepts Inc.’s price movementMarket Performance Recap & Consistent Profit Alerts - Newser
Should I add Treace Medical Concepts Inc. stock to my portfolioIndex Update & Consistent Profit Focused Trading Strategies - خودرو بانک
Truist Securities raises Treace Medical price target to $8 on new products - Investing.com Australia
Can Treace Medical Concepts Inc. stock outperform in a bear market - خودرو بانک
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Nuveen LLC Acquires Shares of 252,700 Treace Medical Concepts, Inc. $TMCI - MarketBeat
Will Treace Medical Concepts Inc. bounce back from current support2025 Volatility Report & Long-Term Growth Stock Strategies - Newser
Treace Medical: Truist Securities Maintains Hold, PT Raised to $8 from $6.6 - AInvest
How to track smart money flows in Treace Medical Concepts Inc.M&A Rumor & Daily Stock Trend Reports - Newser
Tools to monitor Treace Medical Concepts Inc. recovery probabilityJuly 2025 Closing Moves & Verified Momentum Stock Ideas - Newser
What MACD and RSI say about Treace Medical Concepts Inc.2025 Institutional Moves & Weekly Chart Analysis and Guides - Newser
Will Treace Medical Concepts Inc. stock recover after recent dropJuly 2025 Institutional & Growth Focused Entry Reports - Newser
Treace Medical Investor Day Presentation by CEO John Treace - AInvest
Transcript : Treace Medical Concepts, Inc.Analyst/Investor Day - MarketScreener
Combining machine learning predictions for Treace Medical Concepts Inc.July 2025 Trends & Free Low Drawdown Momentum Trade Ideas - Newser
Real time breakdown of Treace Medical Concepts Inc. stock performanceWeekly Gains Summary & Daily Stock Trend Watchlist - Newser
Sector ETF performance correlation with Treace Medical Concepts Inc.Portfolio Performance Summary & Growth Focused Investment Plans - Newser
Key metrics from Treace Medical Concepts Inc.’s quarterly dataBuy Signal & Accurate Buy Signal Notifications - Newser
What makes Treace Medical Concepts Inc. stock price move sharply2025 Growth vs Value & Fast Gain Stock Trading Tips - Newser
Stock Analysis: Can Treace Medical Concepts Inc. stock outperform in a bear marketTrade Exit Report & Community Verified Watchlist Alerts - khodrobank.com
Important Notice to Long-Term Shareholders of Ibotta, Inc. - GlobeNewswire
Will Treace Medical Concepts Inc. benefit from macro trendsWatch List & Reliable Price Breakout Alerts - Newser
Treace Medical Concepts Inc. stock retracement – recovery analysisWeekly Market Report & Low Volatility Stock Recommendations - Newser
Treace Medical Concepts Inc. stock trend forecast2025 Trading Volume Trends & Real-Time Volume Surge Alerts - Newser
How to interpret RSI for Treace Medical Concepts Inc. stockBuy Signal & Consistent Return Investment Signals - Newser
트리스 메디컬 컨셉트 (TMCI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.78%
0.31%
자본화:
|
볼륨(24시간):